Skip to content
10-Q

Quarterly Report

Apogee Therapeutics, Inc. APGE

0000950170-25-106234

← back to feed
Filed
Aug 11, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted Q2 2025 · Jun 30, 2025 58.43M sh
Shares Diluted Q2 2025 · Jun 30, 2025 58.31M sh
Shares Diluted Q2 2025 · Jun 30, 2024 56.52M sh
Shares Diluted Q2 2025 · Jun 30, 2024 53.35M sh
Shares Outstanding Q2 2025 · Jun 30, 2025 58.56M sh
Shares Outstanding Q2 2025 · Dec 31, 2024 58.06M sh
Capex Q2 2025 · Jun 30, 2025 $5.09M
Capex Q2 2025 · Jun 30, 2024 $402K
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$110.51M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$60.94M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $124.19M
Cash And Equivalents Q2 2025 · Jun 30, 2024 $307.3M
Current Liabilities Q2 2025 · Jun 30, 2025 $31.55M
Current Liabilities Q2 2025 · Dec 31, 2024 $28.56M
Total Liabilities Q2 2025 · Jun 30, 2025 $38.37M
Total Liabilities Q2 2025 · Dec 31, 2024 $37.16M
Current Assets Q2 2025 · Jun 30, 2025 $516.12M
Current Assets Q2 2025 · Dec 31, 2024 $529.71M
Total Assets Q2 2025 · Jun 30, 2025 $657.77M
Total Assets Q2 2025 · Dec 31, 2024 $753.95M
Eps Diluted Q2 2025 · Jun 30, 2025 −$1.13
Eps Diluted Q2 2025 · Jun 30, 2025 −$2.08
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.60
Eps Diluted Q2 2025 · Jun 30, 2024 −$1.24
Eps Basic Q2 2025 · Jun 30, 2025 −$1.13
Eps Basic Q2 2025 · Jun 30, 2025 −$2.08
Eps Basic Q2 2025 · Jun 30, 2024 −$0.60
Eps Basic Q2 2025 · Jun 30, 2024 −$1.24
Sga Expense Q2 2025 · Jun 30, 2025 $17.46M
Sga Expense Q2 2025 · Jun 30, 2025 $34.17M
Sga Expense Q2 2025 · Jun 30, 2024 $10.92M
Sga Expense Q2 2025 · Jun 30, 2024 $20.38M
Rd Expense Q2 2025 · Jun 30, 2025 $55.7M
Rd Expense Q2 2025 · Jun 30, 2025 $102.09M
Rd Expense Q2 2025 · Jun 30, 2024 $33.21M
Rd Expense Q2 2025 · Jun 30, 2024 $61.92M
Net Income Q2 2025 · Jun 30, 2025 −$66.1M
Net Income Q2 2025 · Jun 30, 2025 −$121.44M
Net Income Q2 2025 · Mar 31, 2025 −$55.34M
Net Income Q2 2025 · Jun 30, 2024 −$33.82M
Net Income Q2 2025 · Jun 30, 2024 −$65.91M
Net Income Q2 2025 · Mar 31, 2024 −$32.09M
Operating Income Q2 2025 · Jun 30, 2025 −$73.17M
Operating Income Q2 2025 · Jun 30, 2025 −$136.26M
Operating Income Q2 2025 · Jun 30, 2024 −$44.12M
Operating Income Q2 2025 · Jun 30, 2024 −$82.3M